#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gaucher's disease type I Anti-HLA antibody test positive Neuronal ceroid lipofuscinosis Chronic myeloid leukaemia White matter lesion Amyotrophic lateral sclerosis Vulval cancer Cerebral arteriovenous malformation haemorrhagic Hyperadrenocorticism Congenital nephrogenic diabetes insipidus Chronic granulomatous disease Hereditary ataxia Thrombotic thrombocytopenic purpura Antisynthetase syndrome Prostate cancer More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Life with Disease Mucopolysaccharidosis II – Basic Information Richter’s syndrome – Diagnostics Langerhans cell sarcoma – Basic Information Biotinidase deficiency Netherton’s syndrome – Basic Information Marginal zone lymphoma refractory – Basic Information Leukoencephalopathy – Basic Information Pulmonary fibrosis – Diagnostics Vascular malformation – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nizatidine IDOR-1117-2520C VANDETANIB POLYSORBATE 80 Pentixather Loperamide Hydrochloride ISPAGHULA HUSK Betula Verrucosa (108) Spartalizumab Lumasiran Elacestrant Dihydrochloride Human Coagulation Factor Ix Tasquinimod Thiamine Letrozole Tazobactam Sodium Rilpivirine Tropicamide Azd4831 Magnesium Chloride More therapies…

    Learn about Your Condition

    Anaemia of pregnancy Thalassaemia beta Skin wrinkling Merycism Oropharyngeal cancer Lung transplant rejection Paraesthesia Bartonellosis Alopecia areata Meningioma malignant Primary hypogonadism Cryoglobulinaemia Hepatic encephalopathy Fibrosarcoma Hepatitis D More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Nivolumab and Nivolumab Plus Relatlimab for Patients with Advanced or Metastatic Skin Squamous Cell Carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Relatlimab
    • Nivolumab
    Austria

  • Study on the Use of Gallium Citrate Ga-68 for Diagnosing Chronic Infections in Artificial Hip and Knee Joints

    Recruiting

    2 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Gallium Citrate Ga-68
    France

  • Study of ADS-010 for Adults with Facioscapulohumeral Muscular Dystrophy Type 1

    Recruiting

    2 1 1
    Investigated Diseases:
    • Facioscapulohumeral muscular dystrophy
    Investigated Drugs:
    • Ads-010
    • Sodium Chloride
    Germany Italy The Netherlands Spain

  • Study on the Effect of Levobupivacaine in Reducing Chronic Pain After Open Inguinal Hernia Repair in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Abdominal pain
    • Abdominal wall pain
    • Hernia repair
    Spain

  • Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anifrolumab
    Austria Belgium Bulgaria Czechia Denmark France +7

  • Study on Surgical Treatment with or without Apalutamide for Patients with High-Risk Prostate Cancer Eligible for Radical Prostatectomy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Apalutamide
    Italy
Previous Page
1 … 337 338 339 340 341 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!